CHRNA7 and early-onset autosomal dominant Alzheimer disease: Besides, activating α7-nAChR has been demonstrated to benefit for treating many inflammation related diseases, such as arthritis, shock, stroke, myocardial infarction and Alzheimer's disease [17], [55]–[58], which will also contribute to the prevention and treatment of diabetic complications.